Massachusetts Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.

Press releases published on May 18, 2026

Visology Announces Expansion Across Greater Boston Through Its Relationship with Stop & Shop Beginning Spring 2026
TelluBase Edición Semestral H1 2026 Ya Disponible por Tellusant
EyeCool Therapeutics Announces Publication of First Randomized Controlled Trial of Novel Cooling Device for COSP
Access Fixtures Launches New ORBE Field-Selectable Architectural Dome-Top LED Louvered Bollard Light
Rare Stamp Discovery Worth Millions to be Offered at Auction for the First Time
Cullinan Therapeutics to Present Initial Clinical Data for CLN-978 in Treatment-Refractory Rheumatoid Arthritis and Systemic Lupus Erythematosus at EULAR 2026 Congress
Precision Optics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
Beam Therapeutics Presents Recently Reported Topline Clinical Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the American Thoracic Society (ATS) 2026 International Conference
Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
Upstream Bio Presents New Data from Phase 2 VIBRANT Trial of Verekitug Demonstrating Improvement in Asthma Symptom Control in Participants with CRSwNP and Comorbid Asthma at the ATS 2026 International Conference
Akari Therapeutics to Present at A.G.P.’s Annual Healthcare Company Showcase
Parexel Launches ParexelAI™, Delivering AI Innovation to Accelerate Clinical Development
Alpha Tau to Participate in May Investor Conferences
Stop & Shop Boosts Affordability with Lower Everyday Prices on Thousands of Items at All Stores in New York and New Jersey

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Massachusetts Weekly

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.